
    
      This study is a prospective, single-center, non-randomized, single-arm study. Each enrolled
      subject will undergo periodic follow-up evaluations involving physical exams, computed
      tomography angiography (CTA) of chest, abdomen and pelvis, abdominal duplex ultrasound,
      creatinine measurement, quality of life questionnaire at specific, protocol-defined intervals
      for a period of five years following the physician-modified Cook ZenithÂ® Alpha Endovascular
      Graft implant.
    
  